Merck, MIR2700, TransIT®</SUP>-293

General description
TransIT®-293 Transfection Reagent is specifically optimized to provide exceptional transfection efficiency of plasmid DNA in HEK 293 and cell types of associated lineage. TransIT®-293 provides all the attributes of the trusted TransIT series of transfection reagents: high transfection efficiency, low toxicity, serum compatibility, simplicity of use and reproducibility.
Transfections with TransIT®-293 Reagent do not require medium changes and can be carried out in serum-containing medium. TransIT®-293 is suitable for both transient and stable transfection and can be used for many applications such as gene expression, viral production, shRNA expression and promoter analysis.
Features and Benefits
Unique Formulation – Maximize transfection performance in HEK 293 cells
High Efficiency Delivery – Achieve 75-85% transfection efficiency to ensure experimental success

Deliver Single or Multiple Plasmids – Ideal for specialized applications, such as virus production

Low Cellular Toxicity – Maintain cell density and reduce experimental biases

Other Notes
Biological Source: raw materials that are derived from animals.

Suitable for: HEK 293 transfection
Legal Information
TransIT is a registered trademark of Mirus Bio